GlassScriptPhysician profile
Eva M Crooke
NPI 1457519738
$4,807.73
in general payments reported to CMS, 2019-2025
43 companies · $405 in 2025
The $405 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $448 · 2021: $485 · 2022: $2,017 · 2023: $566 · 2024: $395 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.50 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $1,409.99 | 2022 | |
| Abbvie INC. | $582.12 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $326.00 | 2023-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $268.78 | 2019-2022 | |
| Hologic Sales and Service, LLC | $194.21 | 2021-2024 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Coopersurgical, INC. | $167.02 | 2020-2025 | Paragard T 380a, Paragard T 380a, Ally II Ups |
| Sumitomo Pharma America, INC. | $163.47 | 2023-2024 | Myfembree |
| Sage Therapeutics, LLC | $151.38 | 2021-2025 | Zurzuvae |
| Myovant Sciences INC. | $134.08 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.00 | 2019-2024 | |
| Myriad Women'S Health, INC. | $114.86 | 2023 | |
| Daiichi Sankyo INC. | $88.12 | 2020-2022 | |
| Exeltis, USA INC. | $81.45 | 2019-2025 | Slynd |
| Pfizer INC. | $80.57 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $73.13 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Crooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.